147 related articles for article (PubMed ID: 27636888)
1. ALK-rearranged Inflammatory Myofibroblastic Tumor of the Placenta, With Observations on Site of Origin.
Schoolmeester JK; Sukov WR
Int J Gynecol Pathol; 2017 May; 36(3):228-229. PubMed ID: 27636888
[No Abstract] [Full Text] [Related]
2. ALK-rearranged inflammatory myofibroblastic tumour of placental membranes.
Squires L; Matsika A; Turner J; Fitness J; Lourie R
Pathology; 2018 Dec; 50(7):777-779. PubMed ID: 30262185
[No Abstract] [Full Text] [Related]
3. Uterine inflammatory myofibroblastic tumors in pregnant women with and without involvement of the placenta: a study of 6 cases with identification of a novel TIMP3-RET fusion.
Cheek EH; Fadra N; Jackson RA; Davila JI; Sukov WR; Uckerman MT; Clayton A; Keeney GL; Halling KC; Torres-Mora J; Schoolmeester JK
Hum Pathol; 2020 Mar; 97():29-39. PubMed ID: 31917155
[TBL] [Abstract][Full Text] [Related]
4. Pregnancy-associated Inflammatory Myofibroblastic Tumors of the Uterus Are Clinically Distinct and Highly Enriched for TIMP3-ALK and THBS1-ALK Fusions.
Devereaux KA; Fitzpatrick MB; Hartinger S; Jones C; Kunder CA; Longacre TA
Am J Surg Pathol; 2020 Jul; 44(7):970-981. PubMed ID: 32271187
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory Myofibroblastic Tumor Associated With the Placenta: Short Tandem Repeat Genotyping Confirms Uterine Site of Origin.
Ladwig NR; Schoolmeester JK; Weil L; Chapman JS; Zaloudek C; Umetsu SE
Am J Surg Pathol; 2018 Jun; 42(6):807-812. PubMed ID: 29505427
[TBL] [Abstract][Full Text] [Related]
6. Anaplastic lymphoma kinase-negative uterine inflammatory myofibroblastic tumor containing the ETV6-NTRK3 fusion gene: a case report.
Takahashi A; Kurosawa M; Uemura M; Kitazawa J; Hayashi Y
J Int Med Res; 2018 Aug; 46(8):3498-3503. PubMed ID: 29900760
[TBL] [Abstract][Full Text] [Related]
7. Uterine inflammatory myofibroblastic tumor: First report of a ROS1 fusion.
Bennett JA; Wang P; Wanjari P; Diaz L; Oliva E
Genes Chromosomes Cancer; 2021 Dec; 60(12):822-826. PubMed ID: 34322931
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory Myofibroblastic Tumor of the Placenta: A Report of a Novel Lesion in 2 Patients.
Banet N; Ning Y; Montgomery EA
Int J Gynecol Pathol; 2015 Sep; 34(5):419-23. PubMed ID: 26262452
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory myofibroblastic tumors associated with the placenta: a series of 9 cases.
Makhdoum S; Nardi V; Devereaux KA; Kunder CA; Nielsen GP; Oliva E; Young RH; Roberts DJ
Hum Pathol; 2020 Dec; 106():62-73. PubMed ID: 32971128
[TBL] [Abstract][Full Text] [Related]
10. The Presence of ALK Alterations and Clinical Relevance of Crizotinib Treatment in Pediatric Solid Tumors.
Felkai L; Bánusz R; Kovalszky I; Sápi Z; Garami M; Papp G; Karászi K; Varga E; Csóka M
Pathol Oncol Res; 2019 Jan; 25(1):217-224. PubMed ID: 29081033
[TBL] [Abstract][Full Text] [Related]
11. A newborn case of jejunal ALK-negative inflammatory myofibroblastic tumor with ETV6-NTRK3 fusion.
Masuda Y; Tsukamoto Y; Zenitani M; Oda Y; Kinoshita I; Kohashi K; Takemoto J; Hirota S; Shibata A; Koda T; Takeshima Y
Pediatr Blood Cancer; 2019 Oct; 66(10):e27902. PubMed ID: 31250485
[No Abstract] [Full Text] [Related]
12. Inflammatory myofibroblastic tumor arising from soft tissues of extremities harboring a novel CLIP2-ALK fusion.
Ding R; Li X; Zhu XM; Song QX; Fan QH; Zhang ZH; Gong QX
Pathol Int; 2020 Oct; 70(10):798-803. PubMed ID: 32716129
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory Myofibroblastic Tumor Arising in the Cul-De-Sac, Mimicking Ectopic Decidua.
Ioannidis I; Huang JH
Int J Gynecol Pathol; 2019 May; 38(3):253-257. PubMed ID: 29620583
[TBL] [Abstract][Full Text] [Related]
14. ALK Immunohistochemistry and Molecular Analysis in Uterine Inflammatory Myofibroblastic Tumor: Proceedings of the ISGyP Companion Society Session at the 2020 USCAP Annual Meeting.
Parra-Herran C
Int J Gynecol Pathol; 2021 Jan; 40(1):28-31. PubMed ID: 33290353
[TBL] [Abstract][Full Text] [Related]
15. Pseudosarcomatous myofibroblastic proliferations of the urinary bladder are neoplasms characterized by recurrent FN1-ALK fusions.
Acosta AM; Demicco EG; Dal Cin P; Hirsch MS; Fletcher CDM; Jo VY
Mod Pathol; 2021 Feb; 34(2):469-477. PubMed ID: 32908253
[TBL] [Abstract][Full Text] [Related]
16. ALK-rearranged Tumors Are Highly Enriched in the STUMP Subcategory of Uterine Tumors.
Devereaux KA; Kunder CA; Longacre TA
Am J Surg Pathol; 2019 Jan; 43(1):64-74. PubMed ID: 29794871
[TBL] [Abstract][Full Text] [Related]
17. ALK, ROS1 and NTRK3 gene rearrangements in inflammatory myofibroblastic tumours.
Yamamoto H; Yoshida A; Taguchi K; Kohashi K; Hatanaka Y; Yamashita A; Mori D; Oda Y
Histopathology; 2016 Jul; 69(1):72-83. PubMed ID: 26647767
[TBL] [Abstract][Full Text] [Related]
18. ALK-1 protein expression and ALK gene rearrangements aid in the diagnosis of inflammatory myofibroblastic tumors of the female genital tract.
Fuehrer NE; Keeney GL; Ketterling RP; Knudson RA; Bell DA
Arch Pathol Lab Med; 2012 Jun; 136(6):623-6. PubMed ID: 22646268
[TBL] [Abstract][Full Text] [Related]
19. ALK inhibition in two emblematic cases of pediatric inflammatory myofibroblastic tumor: Efficacy and side effects.
Brivio E; Zwaan CM
Pediatr Blood Cancer; 2019 May; 66(5):e27645. PubMed ID: 30697903
[TBL] [Abstract][Full Text] [Related]
20. A novel ALK rearrangement in an inflammatory myofibroblastic tumor in a neonate.
Owusu-Brackett N; Johnson R; Schindel DT; Koduru P; Cope-Yokoyama S
Cancer Genet; 2013; 206(9-10):353-6. PubMed ID: 24290361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
